Dr. Ihab Mohammed Deebajah, MD

Dr. Deebajah practices at Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health.

Dr. Deebajah's NPI, 1205807260, was assigned on January 30, 2006. Dr. Deebajah graduated from Jordan University of Science and Technology FOM in 1993. Dr. Deebajah holds Michigan license 4301067420.

Dr. Deebajah's primary practice is Corewell Health Dearborn Hospital, at 18101 Oakwood Blvd, Dearborn, MI 48124 in Wayne County. The practice phone is (313) 593-7125.

Dr. Deebajah's primary practice is Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health. Dr. Deebajah is also affiliated with Corewell Health Farmington Hills Hospital. Dmand AI also links Dr. Deebajah to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deebajah practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Deebajah's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Deebajah is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Deebajah's licenses on file in 2 states: Michigan and Pennsylvania.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pulmonary fibrosis and sleep apnea among the conditions Dr. Deebajah treats.

CMS data shows 3,301 Medicare services from Dr. Deebajah across 18 procedure codes in 2024, for 591 Medicare patients. Medicare paid $252,989 for them.

CMS counts 591 Medicare patients who saw Dr. Deebajah in 2024. The largest group is 65 to 74, with 272 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deebajah's median patient age at 62, with 49% women.

In 2024, Dr. Deebajah wrote 8,479 Medicare Part D claims for 828 patients. 43% of them were for generic drugs. CMS names the drug for 8,249 of them, across 52 drugs with 11 or more claims each, at $2,440,933 in total drug cost. In 2023, CMS named 7,588 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Deebajah for performance year 2024, reported individually. Dr. Deebajah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Deebajah in 2007. Dr. Deebajah's most frequent co-authors are M Safwan Badr, MD and James A. Rowley, MD.

CMS Open Payments shows 477 general payments to Dr. Deebajah from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 92% of the total. GlaxoSmithKline, LLC. paid the most, $115,042.

Dmand AI lists 1 award for Dr. Deebajah, most recently CMS Stage 1 EHR in 2012.

Dr. Deebajah graduated from Jordan University of Science and Technology FOM in 1993.

Dr. Deebajah is in network with 15 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.